Abercrombie & Fitch (ANF)

NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-10-23

$155.82-3.51%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Abercrombie & Fitch’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.3%

+10% or more+5%0%−5%−10% or less

12.94 → 12.90 EPS · FY ending Jan 31, 2028 · 6 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 6 to 6; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	—	1.37B
EPS	$2.9–$3.2	3.063
Operating margin	13%–14%	—
Revenue growth	5%–6%	—
FY 2026 · Annual
Revenue	—	5.53B
EPS	$13.1–$13.6	12.88
Capital expenditure	About $250M	—
Operating margin	14.5%–15%	—
Revenue growth	About 5%	—
FY 2027 · Annual
Revenue	—	5.78B
EPS	—	12.901

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Achieve EPS near $10.6 in fiscal 2026	Profit margins are guided near 12%, supporting earnings.	Broken	EPS falls below $10.0 in FY26	Diluted EPS: $4.17 per share FY2026-Q2; GAAP. Published target: ~$10.6 EPS. Target period is not explicitly aligned with this observation. Source published Sep 4, 20264.17 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: company_financial_results. Reference: 1502c99b-d2de-4556-a419-d2ec98025ec5. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain net sales growth of 3% to 5% in fiscal 2026	A primary condition in Abercrombie & Fitch's published investment case. The stated target is 3% to 5% YoY revenue growth.	Broken	YoY revenue growth falls below 3% in FY26	Revenue growth: 4.81% FY2026-Q2; GAAP. Published target: 3% to 5% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Sep 4, 20264.809774 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: company_financial_results. Reference: 1502c99b-d2de-4556-a419-d2ec98025ec5. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Sustain operating margin near 12% in fiscal 2026	A primary condition in Abercrombie & Fitch's published investment case. The stated target is >=12% operating margin.	Broken	Operating margin falls below 11% in FY26	Operating margin: 19.95% FY2026-Q2; GAAP. Published target: >=12% operating margin. Target period is not explicitly aligned with this observation. Source published Sep 4, 202619.949648 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: company_financial_results. Reference: 1502c99b-d2de-4556-a419-d2ec98025ec5. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-01-31 · fmp

FY2028 EPS$12.90

$11.72 → $12.90 · observed estimates

FY2028 revenue$5.78B

$5.65B → $5.78B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$11.72	$5,651,839,474	5 / 9
2026-07-25	$11.72	$5,651,839,474	5 / 9
2026-07-26	$11.72	$5,651,839,474	5 / 9
2026-07-27	$11.72	$5,651,839,474	5 / 9
2026-07-28	$11.72	$5,651,839,474	5 / 9
2026-07-29	$11.72	$5,651,839,474	5 / 9
2026-07-30	$11.72	$5,651,839,474	5 / 9
2026-07-31	$11.72	$5,651,839,474	5 / 9
2026-08-01	$11.72	$5,651,839,474	5 / 9
2026-08-02	$11.72	$5,651,839,474	5 / 9
2026-08-03	$11.72	$5,651,839,474	5 / 9
2026-08-04	$11.72	$5,651,839,474	5 / 9
2026-08-05	$11.72	$5,651,839,474	5 / 9
2026-08-06	$11.72	$5,651,839,474	5 / 9
2026-08-07	$11.72	$5,650,366,716	5 / 9
2026-08-08	$11.72	$5,650,366,716	5 / 9
2026-08-09	$11.72	$5,650,366,716	5 / 9
2026-08-10	$11.72	$5,650,366,716	5 / 9
2026-08-11	$11.72	$5,650,366,716	5 / 9
2026-08-12	$11.84	$5,639,252,800	5 / 10
2026-08-13	$11.84	$5,639,252,800	5 / 10
2026-08-14	$11.72	$5,650,366,716	5 / 9
2026-08-15	$11.72	$5,650,366,716	5 / 9
2026-08-16	$11.72	$5,650,366,716	5 / 9
2026-08-17	$11.72	$5,650,366,716	5 / 9
2026-08-18	$11.72	$5,650,366,716	5 / 9
2026-08-19	$11.72	$5,650,366,716	5 / 9
2026-08-20	$11.72	$5,650,366,716	5 / 9
2026-08-21	$11.79	$5,655,197,314	5 / 9
2026-08-22	$11.79	$5,655,197,314	6 / 9
2026-08-23	$11.79	$5,655,195,842	6 / 9
2026-08-24	$11.79	$5,655,195,842	6 / 9
2026-08-25	$11.79	$5,655,195,842	6 / 9
2026-08-26	$11.79	$5,655,195,842	6 / 9
2026-08-27	$11.79	$5,655,195,842	6 / 9
2026-08-28	$12.67	$5,767,818,838	6 / 9
2026-08-29	$12.67	$5,767,818,838	6 / 9
2026-08-30	$12.67	$5,767,818,838	6 / 9
2026-08-31	$12.67	$5,767,818,838	6 / 9
2026-09-01	$12.85	$5,767,818,838	6 / 9
2026-09-02	$12.85	$5,767,818,838	6 / 9
2026-09-03	$12.85	$5,767,818,838	6 / 9
2026-09-04	$12.85	$5,767,818,838	6 / 9
2026-09-05	$12.85	$5,767,818,838	6 / 9
2026-09-06	$12.85	$5,767,818,838	6 / 9
2026-09-07	$12.85	$5,767,818,838	6 / 9
2026-09-08	$12.85	$5,767,818,838	6 / 9
2026-09-09	$12.85	$5,767,818,838	6 / 9
2026-09-10	$12.94	$5,769,373,102	6 / 9
2026-09-11	$12.94	$5,769,373,102	6 / 10
2026-09-12	$12.94	$5,769,373,102	6 / 10
2026-09-13	$12.94	$5,769,373,102	6 / 10
2026-09-14	$12.94	$5,769,373,102	6 / 10
2026-09-15	$12.94	$5,769,373,102	6 / 10
2026-09-16	$12.94	$5,769,373,102	6 / 10
2026-09-17	$12.94	$5,769,373,102	6 / 10
2026-09-18	$12.94	$5,769,373,102	6 / 10
2026-09-19	$12.94	$5,769,373,102	6 / 10
2026-09-20	$12.94	$5,769,373,102	6 / 10
2026-09-21	$12.94	$5,769,373,102	6 / 10
2026-09-22	$12.94	$5,769,373,102	6 / 10
2026-09-23	$12.94	$5,769,373,102	6 / 10
2026-09-24	$12.94	$5,769,373,102	6 / 10
2026-09-25	$12.94	$5,769,373,102	6 / 10
2026-09-26	$12.94	$5,769,373,102	6 / 10
2026-09-27	$12.94	$5,769,373,102	6 / 10
2026-09-28	$12.94	$5,769,373,102	6 / 10
2026-09-29	$12.94	$5,769,373,102	6 / 10
2026-09-30	$12.94	$5,769,373,102	6 / 10
2026-10-01	$12.94	$5,769,373,102	6 / 10
2026-10-02	$12.94	$5,769,373,102	6 / 10
2026-10-03	$12.94	$5,769,373,102	6 / 10
2026-10-04	$12.94	$5,769,373,102	6 / 10
2026-10-05	$12.94	$5,769,373,102	6 / 10
2026-10-06	$12.94	$5,769,373,102	6 / 10
2026-10-07	$12.94	$5,769,373,102	6 / 9
2026-10-08	$12.94	$5,769,373,102	6 / 9
2026-10-09	$12.94	$5,769,373,102	6 / 9
2026-10-10	$12.94	$5,769,373,102	6 / 9
2026-10-11	$12.94	$5,769,373,102	6 / 9
2026-10-12	$12.94	$5,769,373,102	6 / 9
2026-10-13	$12.94	$5,769,373,102	6 / 9
2026-10-14	$12.94	$5,769,373,102	6 / 9
2026-10-15	$12.95	$5,776,323,102	6 / 9
2026-10-16	$12.95	$5,776,323,102	6 / 9
2026-10-17	$12.95	$5,776,323,102	6 / 9
2026-10-18	$12.95	$5,776,323,102	6 / 9
2026-10-19	$12.95	$5,776,323,102	6 / 9
2026-10-20	$12.95	$5,776,323,102	6 / 9
2026-10-21	$12.89	$5,777,749,591	6 / 9
2026-10-22	$12.90	$5,776,687,125	6 / 9
2026-10-23	$12.90	$5,776,687,125	6 / 9
2026-10-24	$12.90	$5,776,687,125	6 / 9

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	8	5	1
2026-06-01	8	4	1
2026-07-01	8	5	1
2026-08-01	8	8	1
2026-09-01	8	8	0
2026-10-01	9	7	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 9 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Wolfe ResearchOct 21

$181.00New observation · no comparable prior

$0$99.55$199.10

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Achieve EPS near $10.6 in fiscal 2026Published status: Broken
Maintain net sales growth of 3% to 5% in fiscal 2026Published status: Broken
Sustain operating margin near 12% in fiscal 2026Published status: Broken

Next proof point

Nov 24, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.9%Typical daily move · historical

Downside history

-45.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Abercrombie & Fitch outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

ANF is a consumer-discretionary growth business with a record of consistent sales growth, rather than a turnaround story. Its multi-year view is intact and has recently shifted from mixed to mildly favorable, though the evidence carries medium confidence.

What's priced into Abercrombie & Fitch

Valuation is roughly aligned with peers, and the market’s expectations appear broadly aligned with the business outlook. The priced-in assessment is marked justified, with low fragility, so the evidence does not point to an unusually stretched expectations gap.

What the fundamentals likely do

Near term, management is on track with its fiscal 2026 sales-growth and share-repurchase priorities, while capital spending progress is mixed. Recent earnings beats and 15 consecutive quarters of sales growth support the multi-year thesis, but a past deep earnings miss and a trend of declining surprises remain risks.

What Abercrombie & Fitch hinges on

A guidance cut on the next call would be a meaningful negative for the thesis. Over the near term, continued earnings strength and higher guidance from sector bellwethers TJX, ROST, and BURL would support the sector backdrop; misses or lower guidance could weaken it.